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Print abstract 75 76
Study question: What is the accuracy of triaging patients for ambulatory blood pressure monitoring 77 (ABPM) in routine clinical practice? 78
Methods: This study used a prospective observational cohort design, recruiting patients from ten primary 79 care practices and one hospital in the UK. Consecutive patients aged >18 years referred for ABPM in routine 80 practice were enrolled. All paeticipants underwent ABPM and had the new triage algorithm (PROOF-BP) 81
applied. The proportion correctly classified with hypertension using the triaging strategy was estimated and 82 compared to the reference standard of daytime ABPM. Secondary outcomes included sensitivity, specificity 83
and area under the receiver operator characteristic curve (AUROC) for detecting hypertension. 84
Study answer and limitations: In a population of 887 patients referred for ABPM, the new triaging 85 approach accurately classified hypertensive status in 801 patients (90%, 95% CI 88% to 92%) and had a 86 sensitivity of 97% (95% CI 96% to 99%) and specificity of 76% (95% CI 71% to 81%) for hypertension. 87
Use of triaging, rather than uniform referral for ABPM in routine practice would have resulted in 435 88 patients (49%, 95% CI 46% to 52%) being referred for ABPM and the remainder managed on the basis of 89 their clinic measurements. Of these, 69 (8%, 95% CI 6% to 10%) would have received treatment that would 90 have been deemed unnecessary had they received ABPM. 91
What this study adds: The new triaging strategy accurately classified an individual's hypertensive status 92
with half the utilisation of ABPM compared with usual care. It can therefore be recommended for diagnosis 93 or management of hypertension in patients where ABPM is being considered, particularly in settings where 94 resources may be limited. High blood pressure (hypertension) is an important risk factor for cardiovascular disease,(1) the leading 123 cause of morbidity and mortality worldwide. (2) Hypertension can be managed effectively with 124 antihypertensive medications.(3) Ambulatory blood pressure monitoring (ABPM) is the reference standard 125
for confirming a diagnosis of hypertension, and is now commonly used prior to initiation of treatment. (3)  126 This is because ambulatory blood pressure (BP), compared to clinic blood pressure, has been shown to 127 estimate mean blood pressure more accurately and correlate better with a range of cardiovascular 128
outcomes.(4-6) Indeed, clinic blood pressure often misclassifies true mean blood pressure due to white coat 129 hypertension (high clinic blood pressure with normal ambulatory BP) or the converse, masked hypertension 130
(high ambulatory BP with normal clinic blood pressure) (eFigure 1).(7-9) 131 132
Current strategies for the diagnosis of hypertension recommended by the UK National Institute for Health 133
and Care Excellence (NICE)(10) and the American College of Cardiology/American Heart Association Task 134
Force (11) It has been suggested that triaging patients for ABPM may improve management of hypertension by limiting 144 the use of ABPM to those most likely to be misclassified by clinic blood pressure. (12) The most effective 145 way to triage patients for ABPM has been debated, (13, 14) but recent work proposes an individualised 146 triaging approach, PROOF-BP, using multiple clinic readings and patient characteristics (eFigures 2 and 147
3). (12, 15) 
149
This approach has been validated(12) and appears to be cost-effective in a research setting, (16) To capture as close to 'routine' blood pressures as possible, all participating sites were asked to measure 194 clinic and ambulatory blood pressure but no specific protocol for measurement was suggested or 195 recommended. 'Routine blood pressure' was defined as readings taken by the consulting healthcare 196 professional as part of routine clinical practice.
198
A minimum of three clinic readings taken at the time of referral for ABPM or at monitor fitting were 199 required for inclusion in the study. It is acknowledged that this may not always reflect routine practice(26) 200
(even though it is recommended in guidelines),(10) but the three blood pressure readings were necessary to 201 permit validation of the triaging algorithm. Each site was offered a validated automated blood pressure 202 monitoring device (Omron M10-IT, Omron Corporation, Kyoto, Japan) to assist with the collection of 203 multiple clinic blood pressure readings, but were given the option to continue using their own monitor, so 204 long as at least three readings were taken and recorded. To our knowledge, all readings were taken with the 205 physician or nurse present in the room. ABPM was conducted using the practice/hospital's own ambulatory 206 monitor and fitted by a trained nurse or allied health professional. Some practices in Primary Care only 207 collected daytime ambulatory pressures. Details of clinic and ambulatory blood pressure monitors used at 208 each site are given in the online appendix (eTable 1, online appendix).
210
The PROOF-BP triaging approach 211
The triaging strategy applied an algorithm to three blood pressure readings taken at the clinic appointment, 212 combined with information from an individual's electronic health record: age, sex, BMI, hypertensive and 213 treatment history and the presence of cardiovascular disease (eFigures 2 and 3, online appendix).(12) This 214 algorithm identified three groups: those with definitively normal blood pressure, those with definitively high 215 blood pressure and those requiring further investigation using ABPM (see extended methods in online 216 appendix for detail). 217 218 219
Primary outcome 220
The primary outcome of this study was the proportion correctly classified with hypertension using the 221 triaging strategy compared to the reference standard of daytime ABPM (using a threshold for hypertension of 222 ≥135/85 mmHg).(10, 11, 27) This was defined as the proportion of patients with sustained hypertension (true 223 positives), normotension (true negatives), white coat hypertension (false positives) and masked hypertension 224 (false negatives).
226
Secondary outcomes 227
The sensitivity (for detecting hypertension in patients with the condition), specificity (for ruling out 228 hypertension in those without the condition), positive and negative predictor values were estimated and 229 compared to guideline strategies for measuring blood pressure from the UK,(10) US,(11) Europe,(27) 230
Canada (28) and Japan (29) Descriptive statistics were used to describe the number of patients classified with sustained hypertension, 237
white coat hypertension, normotension and masked hypertension with the triaging approach (the primary 238 outcome) using daytime ABPM as the reference standard. These were used to calculate the sensitivity, 239 specificity, positive and negative predictor values of the triaging approach and the total proportion of 240 participants with correctly classified hypertensive status and proportion that would have been referred for 241
ABPM. 242 243
To examine model performance, a logistic regression model was constructed with true hypertension (defined 244 by daytime ABPM) as the dependant outcome variable and classification using the triaging approach as the 245 independent predictor variable. From this model the area under the receiver operating characteristic 246 (AUROC) curve statistic was estimated. Further analyses were conducted examining the primary outcomes 247
using different definitions of clinic and ambulatory blood pressure (see online appendix).
249
Post-hoc analyses 250
Post-hoc analyses were undertaken to examine performance of the PROOF-BP algorithm on its own (without 251 additional ABPM) and this was compared to other blood pressure measurement strategies (employed without 252 ABPM). 10 11 [30] [31] [32] Subgroup analyses of the sensitivity and specificity of the PROOF-BP triaging approach 253 were undertaken and accompanied by one additional non pre-specified subgroup: patients in whom the 254 treating clinician's own monitor was used to measure clinic blood pressure vs. those where monitors were 255 provided by the research team. 256 257
All analyses were conducted using STATA version 13.1 (MP parallel edition, StataCorp, Texas, USA).
258
Results are presented as means or proportions, with standard deviations or 95% confidence intervals, unless 259 otherwise stated. 260 261
Sample size 262
Based on the original validation of the PROOF-BP prediction model,(12) accrual of data from at least 800 263 patients was required for estimation of hypertensive status with an accuracy of ±1-3% (see eTable 3, online 264 appendix). (25) A sample size of up to 1000 patients was specified to ensure that the pre-specified sub-group 265 analysis could be adequately powered. 266 267 268
Patient and public involvement 269
Patients with a history of hypertension were approached to discuss the study at the design phase of the 270 project. In particular their opinions were sought on the methods of recruitment and patient facing study 271 literature, prior to ethics and NHS R&D applications.
273
Approvals 274
Ethical approval for this study was obtained from the National Research Ethics Service Committee South 275
Central and 61% of the total population were taking at least one antihypertensive medication. Patients attending 290
Secondary Care were younger and had higher blood pressure, more co-morbidities and were taking more 291
antihypertensive medications (table 1) . Most patients were referred for ABPM due to suspected hypertension 292
or uncontrolled blood pressure (eTable 4).
294
Primary analysis 295
The triaging strategy (algorithm used in combination with ABPM) predicted true blood pressure (true 296 positives 66%, 95% CI 63% to 69%; true negatives 25%, 95% CI 22% to 27%) with a low error rate (false 297 positives 8%, 95% CI 6% to 10%; false negatives 2%, 95% CI 1% to 3%) (table 2). The triaging strategy 298 resulted in 49% (95% CI 46% to 52%) being referred for ABPM and the remainder managed on the basis of 299 their clinic measurements. Of the latter, 69 (8%, 95% CI 6% to 10%) would have received treatment that 300
would have been deemed unnecessary had they received an ABPM (table 2) . 301 302
Secondary analysis 303
The triaging strategy had a sensitivity of 97% (95% CI 96% to 99%) and specificity of 76% (95% CI 71% to 304 81%) and an AUROC of 0.86 (95% CI 0.84 to 0.89) for predicting true hypertension (table 3) . It would have 305 resulted in higher sensitivity and negative predictive values, but lower specificity and positive predictive 306 values compared to other diagnostic strategies, had they been applied to this population (including that 307 recommended in the UK (eTables 5 and 6, online appendix). 308 309
The sensitivity of the triaging strategy was consistently high (95% to 100%) regardless of the setting, 310
underlying prevalence of hypertension, subgroup population or clinic blood pressure monitor used (table 3  311 and figure 2). Specificity was affected by the population, with values as low as 60% in patients with chronic 312 kidney disease and as high as 85% in patients with no previous diagnosis of hypertension (figure 2). 313
Hypertensive status was correctly classified in 87-91% of patients, regardless of the setting, patient 314 characteristics, co-morbidities or history of hypertension and/or treatment ( figure 3 ). However, a lower 315 prevalence of hypertension with more individuals with intermediate blood pressures resulted in more 316 referrals for ABPM in a Primary Care setting (59% vs. 42% [Secondary Care]) and in those patients with no 317 history of hypertension (62% vs. 44% [history of hypertension]) or antihypertensive prescription (56% vs. 318 44% [existing prescription]) ( figure 4 ). 319 320
The triaging approach performed consistently well in terms of hypertensive classification and lower 321 utilisation of ABPM, regardless of the number of clinic blood pressure readings or period of 24 hours used 322
for ABPM readings (eTable 7 This study aimed to prospectively validate a new approach to determine who should be offered ABPM for 331 suspected or poor control of hypertension in real world settings. In a population being referred for ABPM, 332
use of a triaging strategy was found to capture nearly all patients with hypertension whilst resulting in half 333 the number of referrals for resource intensive ABPM compared to usual care. However, such a strategy 334
would misclassify as hypertensive 1 in 4 of those without hypertension, potentially leading to unnecessary 335 treatment. Used in a diagnostic situation in people without a prior diagnosis of hypertension, this 336 misclassification of normotensive individuals was reduced to 1 in 7. These findings suggest the potential for 337 diagnosing and managing hypertension using a triaging strategy to reduce the need for ABPM.
339
Strength and weaknesses 340
This study was conducted according to a pre-published, peer reviewed protocol with analyses undertaken in 341 line with a pre-specified analysis plan. The study included 98.8% of patients attending routine practice 342 during the study period, suggesting it is likely to be representative of the target population (those who have 343
an indication for ABPM), and was sufficiently powered to examine key outcomes.
345
Unlike the previous studies in which the PROOF-BP triaging algorithm has been previously validated, (12, 346 30-33) the measurement of clinic blood pressure was not standardised in terms of requiring healthcare 347 professionals to use certain monitors or conform to a specific measurement protocol. This was deliberate in 348 an attempt to replicate readings taken in routine clinical practice where blood pressure measurement 349 techniques can vary. (34) It is recognised that such readings may not truly reflect routine practice either, since 350 healthcare professionals knew they were participating in a research study and validated monitors were 351 provided to some sites to aid the capture of three consecutive clinic readings. (32) In total, six of the eleven 352 participating sites used the validated clinic blood pressure monitors supplied by the research team but this 353 had no impact on the performance of the triaging approach.
355
The study included patients in whom the treating physician felt ABPM was appropriate. In the majority of 356 cases this was due to suspected hypertension or apparently uncontrolled blood pressure (eTable 4, online 357 appendix). This included patients with no history of hypertension (i.e. those referred for diagnosis) and those 358 already prescribed blood pressure lowering medications (i.e. those referred for management of hypertension).
359
The findings are therefore widely applicable to patients undergoing diagnosis and also those in whom the 360 consulting physician is considering treatment intensification but is unsure if this is appropriate. Whilst 361 additional monitoring is not recommended in those with normal blood pressure,(10, 11, 27) 22% of the 362 present cohort had clinic readings below 140/90 mmHg prior to ABPM and 9% proved to have masked 363 hypertension which is consistent with previous prevalence estimates. (35) (36) (37) 
365 366
Comparison with other literature 367
Few studies have previously identified an effective method for triaging patients for out-of-office blood 368 pressure monitoring, and none have externally validated such a method using data from a 'routine' clinical 369
setting. The original PROOF-BP derivation paper reported good performance of the algorithm when used in 370 combination with ABPM, with a sensitivity of 96% and specificity of 87%. Viera et al., (13) examined the 371 optimal threshold for referral for out-of-office monitoring based on automated clinic blood pressure levels in 372 patients with normal clinic pressure for detection of masked hypertension. They reported a sensitivity of 76% 373 and specificity of 58% for a clinic blood pressure threshold of 120 mmHg systolic. In practice, such a 374 threshold would have limited accuracy and efficiency, missing 1 in 4 hypertensive patients and resulting in a 375 large number of patients being referred for ABPM. As such, they did not recommend this approach for use in 376
routine clinical practice. The PROOF-BP triaging strategy examined here uses an individualised approach, 377 taking into account a patient's clinic blood pressure level, variability and underlying cardiovascular risk. It is 378
an approach which maximises the accuracy of hypertensive classification whilst minimising ABPM use 379 compared to usual care, which uses fixed thresholds for referral in all patients.
381
Implications for clinical practice 382
Use of a triaging approach would significantly reduce the proportion of individuals requiring ABPM at the 383 expense of "over treating" a small proportion of individuals. The triaging algorithm performed consistently 384 across sensitivity analyses and sub-group analyses. Because the triaging mechanism is based on thresholds of 385 adjusted clinic blood pressure, scenarios where a greater number of individuals have blood pressures close to 386 the diagnostic threshold for hypertension are likely to result in greater numbers of patients being referred for 387
ABPM. The greater the use of ABPM, the more accurate the triaging strategy was (in patients with no 388 history of hypertension the sensitivity was 95%, specificity was 85% but 61% were referred for ABPM).
389
Where ABPM facilities are widely available, clinicians may therefore wish to consider additional use of 390 ABPM, where the risk of misdiagnosis is great but an individual is not within the triaging range. This could 391
include younger, lower risk individuals for whom a lifetime of treatment may have an impact on their quality 392 of life. However, in low and middle income countries where resources might be more stretched, the PROOF-393 BP triaging approach represents an alternative option which maximises the benefits of ABPM and targets 394 those with the most to gain. 395 396
These data suggest that the PROOF-BP triaging strategy may be used in both Primary and Secondary Care 397
wherever ABPM is being considered to rule out white-coat hypertension. To facilitate uptake, the algorithm 398 is freely available as a calculator online (https://sentry.phc.ox.ac.uk/proof-bp) and could be incorporated into 399 clinic computer systems, smartphone blood pressure management apps and Bluetooth enabled monitors, 400
providing GPs and hospital physicians with instant feedback and management recommendations in terms of 401 referral or treatment.
403
Conclusions 404
This prospective, external validation study demonstrates the accuracy of the PROOF-BP algorithm as a tool 405
for triaging patients for ABPM in 'routine' practice. Used in conjunction with ABPM, the algorithm 406 identifies most truly hypertensive patients and results in half as many patients being referred for additional 407 ABPM compared to usual care. However, it may lead to a small number of patients taking unnecessary 408 treatment. Such an approach can now be recommended for use in both Primary and Secondary Care, 409
wherever ABPM is being considered to rule out white-coat hypertension or masked hypertension. 410
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